Wolverine Asset Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Wolverine Asset Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62,660	Closed	-$625K	–	2585
2022 Q3	$625K	Sell	62,660 -10,065	-14%	-$99.9K	0.01%	953
2022 Q2	$717K	Buy	72,725 +4,004	+6%	+$39.5K	0.01%	894
2022 Q1	$676K	Buy	68,721 +33,027	+93%	+$324K	0.01%	889
2021 Q4	$347K	Sell	35,694 -6,098	-15%	-$59.7K	﹤0.01%	1112
2021 Q3	$409K	Buy	41,792 +37,168	+804%	+$361K	﹤0.01%	1016
2021 Q2	$44K	Buy	4,624 +3,238	+234%	+$31.5K	﹤0.01%	1715
2021 Q1	$13K	Buy	+1,386	New	+$13.5K	﹤0.01%	1840

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wolverine Asset Management's PKBO Position: Q4 2022 in Review

Wolverine Asset Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 62,660 shares — an estimated $625K sold.

Wolverine Asset Management first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $717K in Q2 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Wolverine Asset Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 62,660 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $625K.
Wolverine Asset Management first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Wolverine Asset Management's Peak Bio, Inc. Common Stock position peaked at $717K in Q2 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.